Navigation Links
Research and Markets - Global Multiple Myeloma Drugs Market 2017-2021 with Amgen, Celgene, Johnson & Johnson, Novartis & Takeda Pharmaceuticals Dominating
Date:1/16/2017

DUBLIN, Jan 16, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Multiple Myeloma Drugs Market 2017-2021" report to their offering.

Global multiple myeloma drugs market to grow at a CAGR of 9.19% during the period 2017-2021.

The report covers the present scenario and the growth prospects of the global multiple myeloma drugs market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of branded and generic drugs used to treat and prevent multiple myeloma. The report also includes a discussion of the key vendors operating in this market.

According to the report, one of the major drivers for this market is growing demand for biologic therapies. The market has been witnessing a growing demand for biologic therapies, which is expected to drive market growth. Biologic therapy is a treatment that triggers the body's immune system to fight myeloma cells. Biologic therapies boost the immune system cells that identify and attack cancer cells. The demand for targeted therapies is due to its higher efficacy than other conventional therapies, which involves in destroying healthy cells too.

The latest trend gaining momentum in the market is emergence of nanomedicine platform. The market has witnessed the emergence of nanomedicine, which is likely to have a positive impact. The lipid-based nanoparticles and polymer-based approaches for the drug delivery are gaining traction in the market, owing to the limitations of current technologies. The existing technologies need numerous cells to detect the presence of a tumor.

Further, the report states that the growing popularity of CAM is expected to hinder growth prospects in the market. With the increasing side effects of conventional drugs, the individuals are seeking CAM therapies. The increased demand for these therapies is also due to the high cost of multiple myeloma therapeutics.

Key vendors

  • Amgen
  • Celgene
  • Johnson & Johnson
  • Novartis
  • Takeda Pharmaceuticals

Other prominent vendors

  • AB Science
  • AbbVie
  • Bristol-Meyer Squibb
  • Celldex Therapeutics
  • Eureka Therapeutics
  • F. Hoffmann-La Roche
  • GlaxoSmithKline
  • ImmunoGen
  • Immunomedics
  • Innate Pharma
  • JW Pharmaceutical
  • Merck
  • Oncolytics Biotech
  • Ono Pharmaceutical
  • Otsuka Pharmaceuticals
  • Prothena Therapeutics
  • Sanofi

Key Topics Covered:

Part 01: Executive summary

Part 02: Scope of the report

Part 03: Market research methodology

Part 04: Introduction

Part 05: Disease overview

Part 06: Pipeline analysis

Part 07: Market landscape

Part 08: Market segmentation by therapy

Part 09: Geographical segmentation

Part 10: Market drivers

Part 11: Impact of drivers

Part 12: Market challenges

Part 13: Impact of drivers and challenges

Part 14: Market trends

Part 15: Vendor landscape

Part 16: Key vendor analysis

Part 17: Appendix

For more information about this report visit http://www.researchandmarkets.com/research/zkdjx6/global_multiple

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/research-and-markets---global-multiple-myeloma-drugs-market-2017-2021-with-amgen-celgene-johnson--johnson-novartis--takeda-pharmaceuticals-dominating-300391332.html


'/>"/>
SOURCE Research and Markets
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Non-Invasive Prenatal Testing (NIPT) Market 2011-2021: Natera Panorama Test will Lead the NIPT Test Market 25% of the Market Share - Research and Markets
2. Vital Signs Monitoring Devices Market is Expected to Reach $5,491 Million by 2022, Globally - Allied Market Research
3. Sterilization Technologies Market Expected to Reach $8,578 Million by 2022, Globally - Allied Market Research
4. Antioxidants Market Expected to Reach $4,531 Million by 2022, Globally - Allied Market Research
5. Dovetail Genomics Launches New Genome Assembly Service Designed to Provide Researchers with Chromosome-Scale Genome Assemblies
6. Research Reports Coverage on Medical Equipment Stocks -- Wright Medical, Varian Medical Systems, MiMedx, and NuVasive
7. How These Research Services Stocks are Faring? -- Myriad Genetics, Qiagen, INC Research, and La Quinta
8. Global Cystic Fibrosis Heat Map and Analysis 2016-2022 - Research and Markets
9. Global Melanoma Heat Map and Framework Analysis Report 2016-2022: Pipeline Products & Marketed Products - Research and Markets
10. Global Immunotherapy Drugs Market to Reach $201 Billion by 2021: Increasing Adoption of Targeted Therapies - Research and Markets
11. In Vitro Diagnostics (IVD) Quality Control Products Market is Expected to Reach $1,052 Million by 2022, Globally - Allied Market Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/17/2019)... ... July 17, 2019 , ... SmartLinx, a leader in workforce ... that further engages healthcare employees by enabling them to take control of their schedules ... show up to work and do more work -- highly engaged business units realize ...
(Date:7/17/2019)... ... July 17, 2019 , ... Argos Risk, ... expansion into the healthcare sector during the second quarter of 2019. Three nationwide ... management join a strong client list in managing and mitigating third-party risk. ...
(Date:7/17/2019)... (PRWEB) , ... July 17, 2019 , ... For the second year in a row, ... This award was given by the Orange County Business Journal, which is the second largest ... award in Orange County, with the additional honor of ranking third place in the medium ...
Breaking Medicine Technology:
(Date:7/17/2019)... ... 17, 2019 , ... The Coalition of Medication-Assisted Treatment Providers ... of its member Opioid Treatment Programs (OTPs) at 12 locations are participating in ... (HCV) with the goal of achieving better outcomes through telemedicine. The study, “Comparison ...
(Date:7/13/2019)... ... ... ZALO , the leading luxury sex toy manufacturer, is now shipping ... the product and its accompanying video click here . , “We are pleased ... the world,” said Mara Epstein, director of sales. “The Hero provides a unique and ...
(Date:7/13/2019)... ... ... The American Med Spa Association (AmSpa) has released the 2019 Medical Spa ... medical spa professionals understand the realities of the industry and make better, more informed ... since AmSpa released the 2017 Medical Spa State of the Industry Report and so ...
(Date:7/11/2019)... ... 11, 2019 , ... The Grain Chain, a farm to ... American Bakers Association (ABA), testified today on the nutritional benefits of bread and ... the Committee’s scientific report, due next year, will form the basis of the ...
(Date:7/9/2019)... ... July 10, 2019 , ... First Healthcare Compliance announced that ... will lead the growing team of client services professionals serving the United States. ... forward to further developing new healthcare client relationships in the United States” states ...
Breaking Medicine News(10 mins):